![Jung Choi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jung Choi
Directeur/Membre du Conseil chez
ANNEXON, INC.
Fortune : 188 430 $ au 30/06/2026
Profil
Jung E.
Choi is currently Chief Executive Officer at Alterome Therapeutics, Inc. since 2025.
Ms. Choi serves as Independent Director at Annexon, Inc. since 2020.
Ms. Choi is Director at New York Blood Center, Inc. and Marea Therapeutics, Inc., and a Member of Aspen Global Leadership Network.
Former roles include Chief Business & Strategy Officer at Global Blood Therapeutics, Inc. from 2015 to 2023, Senior Vice President-Corporate Development at InterMune, Inc. from 2014 to 2015, Senior Vice President-Corporate Development at Chimerix, Inc. from 2011 to 2013, Head-Corporate Development at Gilead Sciences, Inc. from 2002 to 2010, Vice President at Bay City Capital LLC from 1999 to 2001, and Engagement Manager at McKinsey & Co., Inc. from 1997 to 1999.
Education includes undergraduate and MBA degrees from Stanford University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ANNEXON, INC. 0,02 % | 11/06/2026 | 33 000 ( 0,02 % ) | 188 430 $ | 30/06/2026 |
Postes actifs de Jung Choi
| Sociétés | Poste | Début |
|---|---|---|
| ANNEXON, INC. | Directeur/Membre du Conseil | 01/06/2020 |
Aspen Global Leadership Network | Corporate Officer/Principal | - |
Alterome Therapeutics, Inc.
 Alterome Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company for oncology treatment | Directeur Général | 10/04/2025 |
New York Blood Center, Inc.
 New York Blood Center, Inc. Medical/Nursing ServicesHealth Services Operates as blood collection and distribution organization | Directeur/Membre du Conseil | - |
Anciens postes connus de Jung Choi
| Sociétés | Poste | Fin |
|---|---|---|
| GLOBAL BLOOD THERAPEUTICS, INC. | Corporate Officer/Principal | 01/04/2023 |
| INTERMUNE INC | Corporate Officer/Principal | 01/03/2015 |
| CHIMERIX, INC. | Corporate Officer/Principal | 01/01/2013 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/01/2010 |
Bay City Capital LLC
 Bay City Capital LLC Investment ManagersFinance Bay City Capital invests in public and private companies located across the globe. The firm focuses on a broad range of sectors and industries. It provides financing for seed, early and later stage capital transactions. The firm makes co-investments. It acts as a lead investor and takes a seat on the board of directors. | Corporate Officer/Principal | 01/01/2001 |
Formation de Jung Choi
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
68
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
New York Blood Center, Inc.
New York Blood Center, Inc. Medical/Nursing ServicesHealth Services Operates as blood collection and distribution organization | Health Services |
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases | Health Technology |
Chimerix, Inc.
 Chimerix, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for rare epilepsies, cancers and sleep disorders | Health Technology |
Annexon, Inc.
 Annexon, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for neurodegenerative and autoimmune disorders | Health Technology |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bay City Capital LLC
Bay City Capital LLC Investment ManagersFinance Bay City Capital invests in public and private companies located across the globe. The firm focuses on a broad range of sectors and industries. It provides financing for seed, early and later stage capital transactions. The firm makes co-investments. It acts as a lead investor and takes a seat on the board of directors. | Finance |
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides treatment and care of sickle cell disease for inherited blood disorder | Health Technology |
Aspen Global Leadership Network | |
Alterome Therapeutics, Inc.
Alterome Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company for oncology treatment | Health Technology |
Choisissez Zonebourse 
